To enhance clinical relevance, we have concurrently generated a cohort of HNSCC PDO lines, with or without PIK3CA-activating alterations, identified by whole-exome sequencing (WES, Fig.7G). Here, PIK3CA is linked to head and neck squamous cell carcinoma.